Stock
Recursion Pharmaceuticals In
Ticker not mapped · held by 5 managers
Reported value
$4.34M
Holders
5
+2 new · −1 exited
Holders’ est. mark
$108.5K
Price effect on 2 books still in the name
Largest holder
$4.28M
BARCLAYS PLC
Holder count by quarter
Who holds it
Notable only| Investor | Shares | Value | Est. mark | Change |
|---|---|---|---|---|
| BARCLAYS PLC | 633.1K | $4.28M | $107.6K | Cut−$316.2K |
| Leonteq Securities AG | 4.93K | $33.3K | $839 | Cut−$63.8K |
| CHESAPEAKE ASSET MANAGEMENT LLC | 3.54K | $23.9K | — | New |
| Catherine Avery Investment Management LLC | 70 | $473 | — | Held |
| DANSKE BANK A/S | 3 | $20 | — | New |
Who left
- National Philanthropic Trust$164.8K
Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.